Consensus-based care recommendations for adults with myotonic dystrophy type 1

Autor: Valeria A. Sansone, Marla B. Ferschl, Elisa De Mattia, John W. Day, Anne-Berit Ekström, Gordon F. Tomaselli, James E. Hilbert, Todd Goodglick, Tetsuo Ashizawa, Laurie Gutmann, Ericka Simpson, Nicholas E. Johnson, Linda Nguyen, S. H. Subramony, Laurie Sterling, Nathalie Angeard, Marie Kierkegaard, Belen Esparis, Careniña Trujillo, Baziel G.M. van Engelen, Benedikt Schoser, William J. Groh, Tina Duong, Edith H. C. Cup, Elisabetta Roma, Wilma J. Koopman, Shannon L. Venance, Venessa Holland, Kiera Berggren, Janice L.B. Byrne, Ann Broderick, Guillaume Bassez, Daphne Maas, Saman Nazarian, Kari Lane, Chad Heatwole, Peg Nopoulos, Giovanni Meola, Jacinda B. Sampson, Cuixia Tian, Aparajitha Verma, Louis Richer, Marco Bozzali, Subha Raman, Richard T. Moxley, Jack Puymirat, Shahinaz M. Gadalla, Cynthia Gagnon, Katherine D. Mathews, Stefan Winblad, Katy Eichinger, Craig Campbell, Benjamin Gallais, Jeffrey Statland, Richard E. Petty, David J. Moser, Deepak Bhakta, Shree Pandya, Denis Duboc, Chris Turner, Ami Mankodi, Janel Phetteplace, Darren G. Monckton, Molly White, Bruno Eymard, Mark T. Rogers

Publikováno v: Paediatrics Publications
Neurology. Clinical Practice, 8, 6, pp. 507-520
Neurology: Clinical Practice
Neurology: Clinical Practice, 2018, 8 (6), pp.507-520. ⟨10.1212/CPJ.0000000000000531⟩
Neurology. Clinical Practice, 8, 507-520

Purpose of review: Myotonic dystrophy type 1 (DM1) is a severe, progressive genetic disease that affects between 1 in 3,000 and 8,000 individuals globally. No evidence-based guideline exists to inform the care of these patients, and most do not have

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aee3d1ad9bb57439767406ba7ad93787
https://ir.lib.uwo.ca/paedpub/202